X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (16) 16
index medicus (15) 15
breast cancer (14) 14
female (12) 12
estrogen receptor (10) 10
estrogen (9) 9
oncology (8) 8
tamoxifen (8) 8
fes pet (7) 7
pet (7) 7
positron-emission-tomography (7) 7
breast neoplasms - metabolism (6) 6
imaging (6) 6
middle aged (6) 6
positron-emission tomography (6) 6
treatment outcome (6) 6
adult (5) 5
aged (5) 5
cancer (5) 5
estradiol - analogs & derivatives (5) 5
heterogeneity (5) 5
history (5) 5
radiology, nuclear medicine & medical imaging (5) 5
receptors, estrogen - metabolism (5) 5
therapy (5) 5
androgen receptor (4) 4
animals (4) 4
antiquities (4) 4
breast neoplasms - diagnostic imaging (4) 4
breast neoplasms - drug therapy (4) 4
care and treatment (4) 4
expression (4) 4
fulvestrant (4) 4
letrozole (4) 4
metabolic flare (4) 4
metastasis (4) 4
ovarian cancer (4) 4
postmenopausal women (4) 4
biopsy (3) 3
breast (3) 3
breast neoplasms - diagnosis (3) 3
church history (3) 3
endothelial growth-factor (3) 3
estradiol - therapeutic use (3) 3
hematology, oncology and palliative medicine (3) 3
history and criticism (3) 3
immunohistochemistry (3) 3
in-vivo (3) 3
male (3) 3
oestrogen receptor (3) 3
pet imaging (3) 3
phase-ii (3) 3
phase-ii trial (3) 3
progesterone (3) 3
tumor microenvironment (3) 3
tumors (3) 3
abiraterone acetate (2) 2
adrenal androgens (2) 2
advanced breast-cancer (2) 2
aged, 80 and over (2) 2
alpha (2) 2
androgen receptor expression (2) 2
androgens (2) 2
antineoplastic agents - therapeutic use (2) 2
ar antagonist (2) 2
beta (2) 2
bible (2) 2
biological transport (2) 2
bone (2) 2
breast neoplasms - pathology (2) 2
breast-cancer (2) 2
carcinoma, ovarian epithelial (2) 2
cardiology (2) 2
cell-proliferation (2) 2
cells (2) 2
center experience (2) 2
christian literature, early (2) 2
civilization (2) 2
clinical value (2) 2
clinical-significance (2) 2
computer science (2) 2
confidence intervals (2) 2
diagnosis (2) 2
dna methylation (2) 2
endocrine therapy (2) 2
endometrial stromal sarcoma (2) 2
epidermal growth factor (2) 2
estradiol (2) 2
estradiol - metabolism (2) 2
estrogen receptors (2) 2
estrogen-receptors (2) 2
estrogens (2) 2
f-18-fes pet (2) 2
f-18-fluoroestradiol (2) 2
feasibility studies (2) 2
festschriften (2) 2
fluorine-18-labeled estrogens (2) 2
genes (2) 2
hdac inhibitors (2) 2
histoire (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Therapeutic Drug Monitoring, ISSN 0163-4356, 12/2019, Volume 41, Issue 6, pp. 693 - 695
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2015, Volume 33, Issue 15, pp. 527 - 527
Journal Article
Journal of Nuclear Medicine, ISSN 0161-5505, 01/2015, Volume 56, Issue 1, pp. 50 - 50
The estrogen receptor (ER) is expressed in approximately 70% of ovarian cancer tumors. PET of tumor ER expression with the tracer 16-18F-fluoro-17-estradiol... 
Journal Article
Cancer Research, ISSN 0008-5472, 04/2013, Volume 73, Issue 8 Supplement, pp. 4768 - 4768
Journal Article
Journal of Nuclear Medicine, ISSN 0161-5505, 01/2012, Volume 53, Issue 2, pp. 182 - 190
16 alpha -18F-fluoro-17 beta -estradiol (18F-FES) is an estrogen receptor (ER)-specific PET tracer with various potential interesting applications. The precise... 
Journal Article
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 08/2018, Volume 59, Issue 8, p. 1212
Heterogeneity of estrogen receptor (ER) expression in breast cancer is recognized. However, knowledge about varying expression across metastases and... 
Journal Article
Journal Article
Journal of Nuclear Medicine, ISSN 0161-5505, 08/2018, Volume 59, Issue 8, pp. 1212 - 1218
Heterogeneity of estrogen receptor (ER) expression in breast cancer is recognized. However, knowledge about varying expression across metastases and... 
PROGESTERONE | estrogen receptor | breast cancer | FUTURE | ESTROGEN-RECEPTOR BINDING | POSITRON-EMISSION-TOMOGRAPHY | THERAPY | EVOLUTION | IN-VIVO | RESISTANCE | ANDROGEN | tumor microenvironment | F-18-fluoroestradiol PET | PET | tumor heterogeneity | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 2015, Volume 138, Issue 3, pp. 634 - 639
Journal Article
Journal of Nuclear Medicine, ISSN 0161-5505, 01/2015, Volume 56, Issue 1, pp. 50 - 55
The estrogen receptor a (ER alpha) is expressed in approximately 70% of ovarian cancer tumors. PET of tumor ER alpha expression with the tracer 16... 
FES PET | RESPONSIVENESS | estrogen receptor | ovarian cancer | TAMOXIFEN | imaging | BETA | BREAST-CANCER | PHASE-II TRIAL | POSITRON-EMISSION-TOMOGRAPHY | THERAPY | LETROZOLE | F-18-FLUOROESTRADIOL | PROGESTERONE-RECEPTOR | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Journal Article
The Journal of Nuclear Medicine, ISSN 0161-5505, 08/2018, Volume 59, Issue 8, p. 1212
Heterogeneity of estrogen receptor (ER) expression in breast cancer is recognized. However, knowledge about varying expression across metastases and... 
Cluster analysis | Liver | Estrogens | Estrogen | Estrogen receptors | Metastasis | Estradiol | Subgroups | Lymph nodes | Metastases | Confidence intervals | Heterogeneity | Computed tomography | Bones | Lesions | Medical imaging | Fluorine isotopes | Breast cancer | Patients | Sex hormones | Lungs | Breast | Bone | Tumors | Cancer | Lymph
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.